T2 Biosystems, Inc. (TTOO)
OTCMKTS
· Delayed Price · Currency is USD
0.190
-0.045 (-19.15%)
Feb 21, 2025, 3:51 PM EST
T2 Biosystems Employees
T2 Biosystems had 113 employees as of December 31, 2023. The number of employees decreased by 45 or -28.48% compared to the previous year.
Employees
113
Change (1Y)
-45
Growth (1Y)
-28.48%
Revenue / Employee
$67,938
Profits / Employee
-$380,124
Market Cap
3.79M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 109 |
SANUWAVE Health | 31 |
T2 Biosystems News
- 2 months ago - T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. - GlobeNewsWire
- 2 months ago - T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens - GlobeNewsWire
- 3 months ago - T2 Biosystems, Inc. (TTOO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024 - GlobeNewsWire
- 4 months ago - T2 Biosystems, Inc. (TTOO) Business Update Conference Call Transcript - Seeking Alpha
- 4 months ago - T2 Biosystems to Host Business Update Call on October 10, 2024 - GlobeNewsWire
- 4 months ago - T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens - GlobeNewsWire
- 5 months ago - T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union - GlobeNewsWire